Updated 22 weeks ago
FDA Delays Final OK for Type 2 Drug Empagliflozin
Diabetes Health Staff |
Mar 23, 2014 |
The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until "previously observed deficiencies" at the plant where it is manufactured are fixed.
Fatal error: Call to a member function getUrl() on a non-object in /home/diabetes/public_html/browse.php on line 54